Neat1 is a p53-inducible lincRNA essential for transformation suppression

Genes and Development

Volumn 31, Issue 11, 2017, Pages 1095-1108

  Mello, Stephano S ^a   Sinow, Carolyn ^a   Raj, Nitin ^a   Mazur, Pawel K ^a   Bieging Rolett, Kathryn ^a   Broz, Daniela Kenzelmann ^a   Imam, Jamie F Conklin ^a   Vogel, Hannes ^a   Wood, Laura D ^b   Sage, Julien ^a   Hirose, Tetsuro ^c   Nakagawa, Shinichi ^c   Rinn, John ^d   Attardi, Laura D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOKKAIDO UNIVERSITY   (Japan)

^d Harvard University   (United States)

Author keywords

LincRNA; Neat1; P53; Pancreatic cancer; Tumor suppression

Indexed keywords

DOXORUBICIN; K RAS PROTEIN; KI 67 ANTIGEN; LONG UNTRANSLATED RNA; MUCIN 5AC; PROTEIN; PROTEIN NEAT1; PROTEIN P53; UNCLASSIFIED DRUG; NEAT1 LONG NON-CODING RNA, HUMAN; NEAT1 LONG NON-CODING RNA, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA DAMAGE RESPONSE; FIBROBLAST; GENE EXPRESSION; GENOTOXICITY; GLOBAL CHANGE; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PANCREAS ADENOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA SEQUENCE; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CELL TRANSFORMATION; DNA REPAIR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HCT 116 CELL LINE; METABOLISM; PANCREAS CARCINOMA; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DNA REPAIR; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; MICE; RNA, LONG NONCODING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 85025098628     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.284661.116     Document Type: Article

References (89)

1. Adriaens C, Standaert L, Barra J, Latil M, Verfaillie A, Kalev P, Boeckx B, Wijnhoven PWG, Radaelli E, Vermi W, et al. 2016. p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity. Nat Med 22: 861–868.
2. Amankwah EK, Thompson RC, Nabors LB, Olson JJ, Browning JE, Madden MH, Egan KM. 2013. SWI/SNF gene variants and glioma risk and outcome. Cancer Epidemiol 37: 162–165.
3. Arda HE, Benitez CM, Kim SK. 2013. Gene regulatory networks governing pancreas development. Dev Cell 25: 5–13.
4. Balakrishnan A, Penachioni JY, Lamba S, Bleeker FE, Zanon C, Rodolfo M, Vallacchi V, Scarpa A, Felicioni L, Buck M, et al. 2009. Molecular profiling of the ‘plexinome’ in melanoma and pancreatic cancer. Hum Mutat 30: 1167–1174.
5. Biankin AV, Waddell N, Kassahn KS, Gingras M-C, Muthuswamy LB, Johns AL, Miller DK, Wilson PJ, Patch A-M, Wu J, et al. 2012. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491: 399–405.
6. Bieging KT, Mello SS, Attardi LD. 2014. Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer 14: 359–370.
7. Blume CJ, Hotz-Wagenblatt A, Hullein J, Sellner L, Jethwa A, Stolz T, Slabicki M, Lee K, Sharathchandra A, Benner A, et al. 2015. p53-dependent non-coding RNA networks in chronic lymphocytic leukemia. Leukemia 29: 2015–2023.
8. Botcheva K, McCorkle SR, McCombie WR, Dunn JJ, Anderson CW. 2011. Distinct p53 genomic binding patterns in normal and cancer-derived human cells. Cell Cycle 10: 4237–4249.
9. Brady CA, Attardi LD. 2010. p53 at a glance. J Cell Sci 123: 2527–2532.
10. Brady CA, Jiang D, Mello SS, Johnson TM, Jarvis LA, Kozak MM, Broz DK, Basak S, Park EJ, McLaughlin ME, et al. 2011. Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression. Cell 145: 571–583.
11. Castellano E, Molina-Arcas M, Krygowska AA, East P, Warne P, Nicol A, Downward J. 2016. RAS signalling through PI3-ki-nase controls cell migration via modulation of Reelin expression. Nat Commun 7: 11245.
12. Chakravarty D, Sboner A, Nair SS, Giannopoulou E, Li R, Hennig S, Mosquera JM, Pauwels J, Park K, Kossai M, et al. 2014. The oestrogen receptor α-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat Commun 5: 5383.
13. Chedotal A, Kerjan G, Moreau-Fauvarque C. 2005. The brain within the tumor: new roles for axon guidance molecules in cancers. Cell Death Differ 12: 1044–1056.
14. Chen L-L, Carmichael GG. 2009. Altered nuclear retention of mRNAs containing inverted repeats in human embryonic stem cells: functional role of a nuclear noncoding RNA. Mol Cell 35: 467–478.
15. Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, Ma’ayan A. 2013. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14: 128.
16. Chen X, Kong J, Ma Z, Gao S, Feng X. 2015. Up regulation of the long non-coding RNA NEAT1 promotes esophageal squamous cell carcinoma cell progression and correlates with poor prognosis. Am J Cancer Res 5: 2808–2815.
17. Choi YJ, Lin C-P, Ho JJ, He X, Okada N, Bu P, Zhong Y, Kim SY, Bennett MJ, Chen C, et al. 2011. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol 13: 1353–1360.
18. Choudhry H, Albukhari A, Morotti M, Haider S, Moralli D, Smythies J, Schödel J, Green CM, Camps C, Buffa F, et al. 2015. Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival. Oncogene 34: 4482–4490.
19. Clemson CM, Hutchinson JN, Sara SA, Ensminger AW, Fox AH, Chess A, Lawrence JB. 2009. An architectural role for a nuclear noncoding RNA: NEAT1 RNA is essential for the structure of paraspeckles. Molecular Cell 33: 717–726.
20. Conklin JF, Baker J, Sage J. 2012. The RB family is required for the self-renewal and survival of human embryonic stem cells. Nat Commun 3: 1244.
21. Dallol A, Morton D, Maher ER, Latif F. 2003. SLIT2 axon guidance molecule is frequently inactivated in colorectal cancer and suppresses growth of colorectal carcinoma cells. Cancer Res 63: 1054–1058.
22. Direnzo D, Hess DA, Damsz B, Hallett JE, Marshall B, Goswami C, Liu Y, Deering T, Macdonald RJ, Konieczny SF. 2012. Induced Mist1 expression promotes remodeling of mouse pancreatic acinar cells. Gastroenterology 143: 469–480.
23. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. 2013. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29: 15–21.
24. Fox AH, Lamond AI. 2010. Paraspeckles. Cold Spring Harb Perspect Biol 2: a000687.
25. Geissmann Q. 2013. OpenCFU, a new free and open-source software to count cell colonies and other circular objects. PLoS One 8: e54072.
26. Gibb EA, Vucic EA, Enfield KSS, Stewart GL, Lonergan KM, Ken-nett JY, Becker-Santos DD, MacAulay CE, Lam S, Brown CJ, et al. 2011. Human cancer long non-coding RNA transcrip-tomes. PLoS One 6: e25915.
27. Göhrig A, Detjen KM, Hilfenhaus G, Körner JL, Welzel M, Arsenic R, Schmuck R, Bahra M, Wu JY, Wiedenmann B. 2014. Axon guidance factor SLIT2 inhibits neural invasion and metastasis in pancreatic cancer. Cancer Res 74: 1529–1540.
28. Guerra C, Schuhmacher AJ, Cañamero M, Grippo PJ, Verdaguer L, Pérez-Gallego L, Dubus P, Sandgren EP, Barbacid M. 2007. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 11: 291–302.
29. Guerra C, Collado M, Navas C, Schuhmacher Alberto J, Hernán-dez-Porras I, Cañamero M, Rodriguez-Justo M, Serrano M, Barbacid M. 2011. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Cancer Cell 19: 728–739.
30. He C, Jiang B, Ma J, Li Q. 2016. Aberrant NEAT1 expression is associated with clinical outcome in high grade glioma patients. APMIS 124: 169–174.
31. Hirose T, Virnicchi G, Tanigawa A, Naganuma T, Li R, Kimura H, Yokoi T, Nakagawa S, Bénard M, Fox AH, et al. 2014. NEAT1 long noncoding RNA regulates transcription via protein sequestration within subnuclear bodies. Mol Biol Cell 25: 169–183.
32. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M, et al. 2010. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142: 409–419.
33. Hung T, Wang Y, Lin MF, Koegel AK, Kotake Y, Grant GD, Horlings HM, Shah N, Umbricht C, Wang P, et al. 2011. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet 43: 621–629.
34. Hutchinson JN, Ensminger AW, Clemson CM, Lynch CR, Lawrence JB, Chess A. 2007. A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics 8: 39.
35. Jensen JN, Cameron E, Garay MVR, Starkey TW, Gianani R, Jensen J. 2005. Recapitulation of elements of embryonic development in adult mouse pancreatic regeneration. Gastroenterology 128: 728–741.
36. Johnson TM, Hammond EM, Giaccia A, Attardi LD. 2005. The p53QS transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethality. Nat Genet 37: 145–152.
37. Kenzelmann Broz D, Spano Mello S, Bieging KT, Jiang D, Dusek RL, Brady CA, Sidow A, Attardi LD. 2013. Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses. Genes Dev 27: 1016–1031.
38. Kigel B, Rabinowicz N, Varshavsky A, Kessler O, Neufeld G. 2011. Plexin-A4 promotes tumor progression and tumor an-giogenesis by enhancement of VEGF and bFGF signaling. Blood 118: 4285–4296.
39. Kopp Janel L, von Figura G, Mayes E, Liu F-F, Dubois Claire L, Morris Iv John P, Pan Fong C, Akiyama H, Wright Christopher VE, Jensen K, et al. 2012. Identification of Sox9-dependent ac-inar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma. Cancer Cell 22: 737–750.
40. Krizhanovsky V, Lowe SW. 2009. Stem cells: the promises and perils of p53. Nature 460: 1085–1086.
41. Kruiswijk F, Labuschagne CF, Vousden KH. 2015. p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat Rev Mol Cell Biol 16: 393–405.
42. Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, Koplev S, Jenkins SL, Jagodnik KM, Lachmann A, et al. 2016. Enrichr: acomprehensive gene set enrichment analysis Web server 2016 update. Nucleic Acids Res 44: W90–W97.
43. Lahoz A, Hall A. 2013. A tumor suppressor role for srGAP3 in mammary epithelial cells. Oncogene 32: 4854–4860.
44. Lehnert SA, Reverter A, Byrne KA, Wang Y, Nattrass GS, Hudson NJ, Greenwood PL. 2007. Gene expression studies of developing bovine longissimusmuscle from two different beef cattle breeds. BMC Dev Biol 7: 1–13.
45. Léveillé N, Melo CA, Rooijers K, Díaz-Lagares A, Melo SA, Kork-maz G, Lopes R, Moqadam FA, Maia AR, Wijchers PJ, et al. 2015. Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA. Nat Commun 6: 6520.
46. Li T, Kon N, Jiang L, Tan M, Ludwig T, Zhao Y, Baer R, Gu W. 2012. Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence. Cell 149: 1269–1283.
47. Li Y, Li Y, Chen W, He F, Tan Z, Zheng J, Wang W, Zhao Q, Li J. 2015. NEAT expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer. Oncotarget 6: 27641–27650.
48. Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, Lu Z, Wu F, Mo Y-Y. 2013. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res 41: 4976–4987.
49. Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15: 550.
50. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. 1993. p53 is required for radiation induced apoptosis in mouse thy-mocytes. Nature 362: 847–849.
51. Ma Y, Liu L, Yan F, Wei W, Deng J, Sun J. 2016. Enhanced expression of long non-coding RNA NEAT1 is associated with the progression of gastric adenocarcinomas. World J Surg Oncol 14: 1–6.
52. Martinelli P, Canamero M, del Pozo N, Madriles F, Zapata A, Real FX. 2013. Gata6 is required for complete acinar differentiation and maintenance of the exocrine pancreas in adult mice. Gut 62: 1481–1488.
53. Matthaei H, Schulick RD, Hruban RH, Maitra A. 2011. Cystic precursors to invasive pancreatic cancer. Nat Rev Gastroenterol Hepatol 8: 141–150.
54. Mercer TR, Qureshi IA, Gokhan S, Dinger ME, Li G, Mattick JS, Mehler MF. 2010. Long noncoding RNAs in neuronal-glial fate specification and oligodendrocyte lineage maturation. BMC Neurosci 11: 1–15.
55. Mi Je E, Gwak M, Oh H, Ryoung Choi M, Jin Choi Y, Lee SH, Jin Yoo N. 2013. Frameshift mutations of axon guidance genes ROBO1 and ROBO2 in gastric and colorectal cancers with microsatellite instability. Pathology 45: 645–650.
56. Morris JP, Cano DA, Sekine S, Wang SC, Hebrok M. 2010. β-Catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice. J Clin Invest 120: 508–520.
57. Naganuma T, Hirose T. 2013. Paraspeckle formation during the biogenesis of long non-coding RNAs. RNA Biol 10: 456–461.
58. Nakagawa S, Naganuma T, Shioi G, Hirose T. 2011. Paraspeckles are subpopulation-specific nuclear bodies that are not essential in mice. J Cell Biol 193: 31–39.
59. Nakagawa S, Shimada M, Yanaka K, Mito M, Arai T, Takahashi E, Fujita Y, Fujimori T, Standaert L, Marine J-C, et al. 2014. The lncRNA Neat1 is required for corpus luteum formation and the establishment of pregnancy in a subpopulation of mice. Development 141: 4618–4627.
60. Okada N, Lin C-P, Ribeiro MC, Biton A, Lai G, He X, Bu P, Vogel H, Jablons DM, Keller AC, et al. 2014. A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression. Genes Dev 28: 438–450.
61. Olivier M, Hollstein M, Hainaut P. 2010. TP53 mutations in human cancers: origins, consequences, and clinical use. Cold Spring Harb Perspect Biol 2: a001008.
62. Prasanth KV, Prasanth SG, Xuan Z, Hearn S, Freier SM, Bennett CF, Zhang MQ, Spector DL. 2005. Regulating gene expression through RNA nuclear retention. Cell 123: 249–263.
63. Roy N, Malik S, Villanueva KE, Urano A, Lu X, Von Figura G, Seeley ES, Dawson DW, Collisson EA, Hebrok M. 2015. Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation. Genes Dev 29: 658–671.
64. Sánchez Y, Segura V, Marín-Béjar O, Athie A, Marchese FP, Gon-zález J, Bujanda L, Guo S, Matheu A, Huarte M. 2014. Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature. Nat Commun 5: 5812.
65. Sasaki YTF, Ideue T, Sano M, Mituyama T, Hirose T. 2009. MENε/β noncoding RNAs are essential for structural integrity of nuclear paraspeckles. Proc Natl Acad Sci 106: 2525–2530.
66. Sato N, Fukushima N, Chang R, Matsubayashi H, Goggins M. 2006. Differential and epigenetic gene expression profiling identifies frequent disruption of the RELN pathway in pancreatic cancers. Gastroenterology 130: 548–565.
67. Schmitt AM, Chang HY. 2016. Long noncoding RNAs in cancer pathways. Cancer Cell 29: 452–463.
68. Schmitt AM, Garcia JT, Hung T, Flynn RA, Shen Y, Qu K, Payumo AY, Peres-da-Silva A, Broz DK, Baum R, et al. 2016. An inducible long noncoding RNA amplifies DNA damage signaling. Nat Genet 48: 1370–1376.
69. Seymour PA. 2014. Sox9: a master regulator of the pancreatic program. Rev Diabet Stud 11: 51–83.
70. Shi G, Zhu L, Sun Y, Bettencourt R, Damsz B, Hruban RH, Konieczny SF. 2009. Loss of the acinar-restricted transcription factor Mist1 accelerates Kras-induced pancreatic intraepithelial neoplasia. Gastroenterology 136: 1368–1378.
71. Standaert L, Adriaens C, Radaelli E, Keymeulen A, Blanpain C, Hirose T. 2014. The long noncoding RNA Neat1 is required for mammary gland development and lactation. RNA 20: 1844–1849.
72. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci 102: 15545–15550.
73. Sunwoo H, Dinger ME, Wilusz JE, Amaral PP, Mattick JS, Spector DL. 2009. MENε/β nuclear-retained non-coding RNAs are up-regulated upon muscle differentiation and are essential components of paraspeckles. Genome Res 19: 347–359.
74. Takeshima H, Niwa T, Takahashi T, Wakabayashi M, Yamashita S, Ando T, Inagawa Y, Taniguchi H, Katai H, Sugiyama T, et al. 2015. Frequent involvement of chromatin remodeler alterations in gastric field cancerization. Cancer Lett 357: 328–338.
75. Tanaka T, Kuroki T, Adachi T, Ono S, Hirabaru M, Soyama A, Kitasato A, Takatsuki M, Hayashi T, Eguchi S. 2013. Evaluation of SOX9 expression in pancreatic ductal adenocarcinoma and intraductal papillary mucinous neoplasm. Pancreas 42: 488–493.
76. Truitt ML, Ruggero D. 2016. New frontiers in translational control of the cancer genome. Nat Rev Cancer 16: 288–304.
77. Valente Liz J, Gray Daniel HD, Michalak Ewa M, Pinon-Hofbauer J, Egle A, Scott Clare L, Janic A, Strasser A. 2013. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa. Cell Rep 3: 1339–1345.
78. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, et al. 2004. In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303: 844–848.
79. von Figura G, Fukuda A, Roy N, Liku ME, Morris Iv JP, Kim GE, Russ HA, Firpo MA, Mulvihill SJ, Dawson DW, et al. 2014. The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma. Nat Cell Biol 16: 255–267.
80. Vousden KH, Prives C. 2009. Blinded by the light: the growing complexity of p53. Cell 137: 413–431.
81. Wang P, Wu T, Zhou H, Jin Q, He G, Yu H, Xuan L, Wang X, Tian L, Sun Y, et al. 2016. Long noncoding RNA NEAT1 promotes laryngeal squamous cell cancer through regulating miR-107/ CDK6 pathway. J Exp Clin Cancer Res 35: 1–11.
82. Weissman B, Knudsen KE. 2009. Hijacking the chromatin remodeling machinery: impact of SWI/SNF perturbations in cancer. Cancer Res 69: 8223–8230.
83. West JA, Davis CP, Sunwoo H, Simon MD, Sadreyev RI, Wang PI, Tolstorukov MY, Kingston RE. 2014. The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites. Mol Cell 55: 791–802.
84. Wilson BG, Roberts CWM. 2011. SWI/SNF nucleosome remodel-lers and cancer. Nat Rev Cancer 11: 481–492.
85. Wu Y, Yang L, Zhao J, Li C, Nie J, Liu F, Zhuo C, Zheng Y, Li B, Wang Z, et al. 2015. Nuclear-enriched abundant transcript 1 as a diagnostic and prognostic biomarker in colorectal cancer. Mol Cancer 14: 1–12.
86. Younger ST, Kenzelmann-Broz D, Jung H, Attardi LD, Rinn JL. 2015. Integrative genomic analysis reveals widespread enhancer regulation by p53 in response to DNA damage. Nucleic Acids Res 43: 4447–4462.
87. Zeng C, Xu Y, Xu L, Yu X, Cheng J, Yang L, Chen S, Li Y. 2014. Inhibition of long non-coding RNA NEAT1 impairs myeloid differentiation in acute promyelocytic leukemia cells. BMC Cancer 14: 1–7.
88. Zhang JP, Qin HY, Wang L, Liang L, Zhao XC, Cai WX, Wei YN, Wang CM, Han H. 2011. Overexpression of Notch ligand Dll1 in B16 melanoma cells leads to reduced tumor growth due to attenuated vascularization. Cancer Lett 309: 220–227.
89. Zhu L, Shi G, Schmidt CM, Hruban RH, Konieczny SF. 2007. Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia. Am J Pathol 171: 263–273.